Getein Biotech, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -9.01% vs 20.00% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 18.64% vs 30.17% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "267.50",
          "val2": "294.00",
          "chgp": "-9.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "62.90",
          "val2": "90.20",
          "chgp": "-30.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.50",
          "val2": "3.00",
          "chgp": "-16.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "5.10",
          "val2": "5.30",
          "chgp": "-3.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "73.20",
          "val2": "61.70",
          "chgp": "18.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "235.00%",
          "val2": "234.70%",
          "chgp": "0.03%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -9.39% vs -15.12% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -7.83% vs -19.08% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,042.40",
          "val2": "1,150.40",
          "chgp": "-9.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "292.60",
          "val2": "285.60",
          "chgp": "2.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "12.50",
          "val2": "15.40",
          "chgp": "-18.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "9.60",
          "val2": "-0.20",
          "chgp": "4,900.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "211.90",
          "val2": "229.90",
          "chgp": "-7.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "195.00%",
          "val2": "161.80%",
          "chgp": "3.32%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

267.50

294.00

-9.01%

Operating Profit (PBDIT) excl Other Income

62.90

90.20

-30.27%

Interest

2.50

3.00

-16.67%

Exceptional Items

5.10

5.30

-3.77%

Consolidate Net Profit

73.20

61.70

18.64%

Operating Profit Margin (Excl OI)

235.00%

234.70%

0.03%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -9.01% vs 20.00% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 18.64% vs 30.17% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,042.40

1,150.40

-9.39%

Operating Profit (PBDIT) excl Other Income

292.60

285.60

2.45%

Interest

12.50

15.40

-18.83%

Exceptional Items

9.60

-0.20

4,900.00%

Consolidate Net Profit

211.90

229.90

-7.83%

Operating Profit Margin (Excl OI)

195.00%

161.80%

3.32%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -9.39% vs -15.12% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -7.83% vs -19.08% in Dec 2024

All Annual Results